Wegovy® (semaglutide) injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg

Achieve significant, long-term weight loss with Wegovy®, a highly effective prescription injectable medication designed for adults and pediatric patients aged 12 and older. Wegovy is indicated for chronic weight management in individuals with a body mass index (BMI) of 30 or greater (obesity), or 27 or greater (overweight) in the presence of at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.

As a glucagon-like peptide-1 (GLP-1) receptor agonist, Wegovy targets the areas of the brain that regulate appetite and food intake. By mimicking your body’s natural satiety hormones, it slows down stomach emptying and helps you feel fuller longer. When paired with a reduced-calorie meal plan and increased physical activity, Wegovy is clinically proven to help reduce body weight and significantly lower the risk of major adverse cardiovascular events—such as stroke or heart attack—in adults with established cardiovascular disease and obesity or overweight.

Key Features & Benefits

• Powerful Chronic Weight Management: Proven in extensive clinical trials to deliver substantial, sustained reductions in body weight when combined with lifestyle changes.

• Cardiovascular Protection: Clinically demonstrated to reduce the risk of major adverse cardiac events in adults with established heart disease and high BMI.

• Once-Weekly Dosing: Eliminates daily dosing fatigue. Administer your dose just once a week, on the same day, at any time of day, completely independent of meal timing.

• Single-Dose Prefilled Pens: Delivered in a convenient, single-use pen with a hidden needle that retracts automatically upon injection. No dose dialing or needle handling is required.

Dosing & Titration Schedule

Wegovy requires a structured monthly dose escalation schedule to allow your digestive tract to adapt smoothly. Each single-use pen delivers one exact pre-measured dose and is color-coded by strength.

Administration & Storage Instructions

• Route: Subcutaneous injection only. Inject once weekly into the abdomen, thigh, or upper arm. Rotate your injection site with each weekly dose, and never inject into a vein or muscle.

• Unopened Pens: Store inside your refrigerator between 36°F–46°F (2°C–8°C) until the printed expiration date. Do not freeze. Do not use if the pen has been frozen.

• Emergency Storage (Capsule Window): If necessary, unopened Wegovy pens can be kept at room temperature up to 86°F (30°C) for up to 28 days inside their original carton to shield them from direct light. Safely discard the single-use pen immediately after injection.

Important Safety & Prescription Notice: Prescription Required (Rx Only). Wegovy® carries a boxed warning regarding the potential risk of thyroid C-cell tumors. Do not use if you or anyone in your family has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Wegovy contains semaglutide, the same active ingredient found in Ozempic® and Rybelsus®, and must not be used concurrently with them or any other GLP-1 receptor agonist products. The most common side effects are gastrointestinal, including nausea, diarrhea, vomiting, constipation, and abdominal pain. Severe but rare risks include acute pancreatitis, gallbladder problems, and severe allergic reactions. Dosing titrations must be managed under medical supervision.